Increased antimicrobial use during COVID-19: The risk of advancing the threat of antimicrobial resistance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Antibiotic prescribing practices, perceived constraints, and views on antimicrobial resistance among general and orthopedic surgeons in central India.Scientific reports · 2025
   Article
2. TC-14, a cathelicidin-derived antimicrobial peptide with broad-spectrum antibacterial activity and high safety profile.iScience · 2024
   Article
3. Ongoing Strategies to Improve Antimicrobial Utilization in Hospitals across the Middle East and North Africa (MENA): Findings and Implications.Antibiotics (Basel, Switzerland) · 2023
   Article
4. Assessing the Clinical Characteristics and Management of COVID-19 among Pediatric Patients in Ghana: Findings and Implications.Antibiotics (Basel, Switzerland) · 2023
   Article
5. Untargeted Metabolomics Reveals Antidepressant Effects in a Marine Photosynthetic Organism: The DiatomBiology · 2022
   Article
6. Evaluation of Healthcare Students' Knowledge on Antibiotic Use, Antimicrobial Resistance and Antimicrobial Stewardship Programs and Associated Factors in a Tertiary University in Ghana: Findings and Implications.Antibiotics (Basel, Switzerland) · 2022
   Article
7. Azithromycin use and outcomes in patients with COVID-19: an observational real-world study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
   Observational
8. Effect Biomarkers of the Widespread Antimicrobial Triclosan in a Marine Model Diatom.Antioxidants (Basel, Switzerland) · 2022
   Article
9. Increased antimicrobial use during COVID-19: The risk of advancing the threat of antimicrobial resistance.Health science reports · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.